Methods for evaluating efficacy of anti-inflammatory on drugs on joint inflammation

• US 5,799,660 A
• Filed: 02/09/1996
• Issued: 09/01/1998
• Est. Priority Date: 02/09/1996
• Status: Expired due to Fees

• Current Assignee: The Ohio State University Research Foundation
• Original Assignee: The Ohio State Research Foundation
• Inventors: Bertone, Alicia L.
• Primary Examiner(s): Millin, Vincent
• Assistant Examiner(s): CAMPEN, KELLY SCAGGS
• Application Number:
  US08/599,251
• Time in Patent Office: 935 Days
• Field of Search: 128/898, 435/1.1, 435/1.2, 604/27-45
• US Class Current: 128/898
• CPC Class Codes: A61B 5/0215 by means inserted into the body catheters A61M25/00
• CPC Class Codes: A61B 5/026 Measuring blood flow A61B3/1233, A61B3/1241 take precedence
• CPC Class Codes: A61B 5/4528 Joints A61B5/4533, A61B5/4538 take precedence

Abstract

The present invention provides methods for: detecting and quantifying the release of chemical agents, such as anti-inflammatory drugs from the synovial cavity of a joint into the vascular system of the joint; directly measuring the effect of chemical agents on oxygen consumption and the oxygen extraction rate of the joint cells alone; directly and simultaneously measuring the effect of anti-inflammatory drugs on hemodynamic parameters of the joint, and on transsynovial parameters of the joint, such as the permeability of the synovial membrane of a joint, the production of synovial fluid by the joint, and the composition of the synovial fluid of the joint. Each of these methods is useful for evaluating the efficacy of chemical agents on joint inflammation. The methods of the present invention employ a joint preparation which comprises: an isolated joint; a perfusate for perfusating the joint; an inflow conduit for introducing perfusate into the isolated joint; an outflow conduit for receiving perfusate from the isolated joint; means for circulating perfusate through the isolated joint; and oxygenator for oxygenating the perfusate. To quantify the release of a chemical agent, from the synovial cavity of the joint into the vascular system, the chemical agent is injected into the synovial cavity of the isolated joint of the joint preparation. Thereafter, an aliquot of perfusate is withdrawn from the outflow conduit and assayed for presence of the anti-inflammatory drug. Preferably, the amount of drug in the aliquot and the rate of flow of the perfusate from the isolated joint are also measured, so that total amount of the drug which leaks from the synovial cavity is determined.

Claims

1. A joint preparation free of the host animal, comprising:

(a) an isolated joint;

(b) a perfusate for perfusing said isolated joint;

(c) an oxygenator in fluid communication with the perfusate for oxygenating the perfusate;

(d) an inflow conduit having a first end and a second end, the first end in communication with said isolated joint for introducing said perfusate into said isolated joint;

(e) an outflow conduit having a first end and a second end, the first end in fluid communication with the isolated joint for receiving perfusate from the joint, the second end in fluid communication with the second end of the inflow conduit; and

(f) a pump in communication with the inflow conduit or outflow conduit for pumping the perfusate through said isolated joint.

2. The joint preparation of claim 1 further comprising a reservoir for holding the perfusate, said reservoir in fluid communication with the inflow conduit and the outflow conduit.

3. The joint preparation of claim 1 wherein said outflow conduit comprises tubing connected to the veins of the joint vascular system.

4. The isolated joint preparation of claim 1 further comprising a weight measuring system operatively connected with said isolated joint for weighing said isolated joint.

5. A method for measuring the release of a chemical agent from the synovial cavity of a joint to the vascular system of the joint, comprising the following steps:

(a) providing the joint preparation of claim 1,

(b) injecting the chemical agent into the synovial cavity of the isolated joint;

(c) withdrawing an aliquot of perfusate from the outflow conduit;

(d) measuring the concentration of said chemical agent in the aliquot.

6. The method of claim 5, wherein said joint preparation further comprises a perfusate flow measuring device in fluid communication with to said outflow conduit;

and further comprising the steps of;

measuring the rate of flow of perfusate from the veins of said isolated joint; and

calculating the rate of release by dividing the concentration of the chemical agent in the perfusate by the rate of flow of perfusate.

7. The method of claim 5 wherein the joint preparation comprises an isolated equine metacarpophalangeal joint.

8. A method for measuring the partial arterial oxygen pressure and partial venous oxygen pressure of a single joint, comprising:

(a) providing the joint preparation of claim 1;

(b) withdrawing an aliquot of perfusate from the inflow conduit;

(c) measuring the partial pressure of oxygen in the first aliquot of perfusate to determine the partial arterial oxygen pressure of said isolated joint;

(d) withdrawing an aliquot of perfusate from said outflow conduit;

(e) measuring the partial pressure of oxygen in the second aliquot to determine the partial venous oxygen pressure of said isolated joint.

9. The method of claim 8 further comprising the steps of:

(i) measuring the rate of flow of said perfusate into said isolated joint;

(ii) measuring the temperature of said isolated joint;

(iii) measuring the weight of said isolated joint

(iv) measuring the hemoglobin content of said perfusate;

(v) measuring the hemoglobin saturation concentration of said perfusate;

(vi) calculating the amount of oxygen delivered to the joint.

10. A method for measuring the effect of a drug on the permeability of the synovial membrane of a joint, comprising:

(a) providing the isolated joint preparation of claim 1;

(b) injecting a drug into the synovial cavity of the isolated joint;

(c) injecting an indicator compound having a molecular weight of at least 40,000 daltons into the synovial cavity of the isolated joint;

(d) withdrawing an aliquot of perfusate from the outflow conduit; and

(e) assaying for the presence of the indicator compound.

11. The method of claim 10 wherein the joint preparation comprises an isolated equine metacarpophalangeal joint.

12. The isolated joint preparation of claim 1 wherein the isolated joint is an isolated equine metacarpophalangeal joint.

16. A method for evaluating the effect of a chemical agent on an isolated joint comprising:

(a) providing the joint preparation of claim 2 (b) measuring at least two of the following physiological parameters of arterial pressure, venous pressure, capillary pressure, PaO₂, VaO₂, weight of the joint, amount of synovial fluid produced by said isolated joint, concentration of white blood cells in the synovial fluid, concentration of protein in the perfusate fluid, concentration of protein in the synovial fluid, concentration of albumin in the perfusate fluid, concentration of albumin in the synovial fluid, rate of flow of perfusate into the arteries of said joint, rate of flow of said perfusate from the veins of said joint, perfusate flow to the synovium, synovial membrane permeability;

(c) injecting the chemical agent into the synovial cavity of the isolated joint; and

(d) measuring the physiological parameters of step (b) to determine the effect of the chemical agent on said selected physiological parameters.

17. The method of claim 16 wherein at least two of said physiological parameters are measured simultaneously.

18. The method of claim 16 wherein said joint preparation further comprises a fluid flow measuring device connected to said outflow conduit and wherein at least one of said physiological parameters is the rate of flow of perfusate from said isolated joint.

19. The method of claim 16 wherein the joint preparation comprises an isolated equine metacarpophalangeal joint.

13. A joint preparation in fluid communication with a host animal comprising:

(a) an isolated joint;

(b) a perfusate for perfusing said isolated joint;

(c) an inflow conduit having a first end and a second end, the first end in fluid communication with the isolated joint and a second end in fluid communication with the host animal;

(d) an outflow conduit for receiving the perfusate from said isolated joint, said outflow conduit having a first end in fluid communication with said isolated joint and a second end, said second ends of each of said inflow and outflow conduits being connected to the host animal to provide fluid flow from said first conduit through said joint and to said second conduit.

14. The joint preparation of claim 13 further comprising a first pump connected to the inflow conduit for pumping said perfusate into said isolated joint.

15. The joint preparation of claim 13 further comprising a second pump in fluid communication with the outflow conduit for pumping said perfusate from said outflow conduit into the host animal.

20. The joint preparation of claim 13 wherein the isolated joint is an isolated equine metacarpophalangeal joint and the host animal is a horse.